Cargando…
Amyloid Beta Peptides Lead to Mast Cell Activation in a Novel 3D Hydrogel Model
Alzheimer’s disease (AD) is a prevalent neurodegenerative disease and the world’s primary cause of dementia among the elderly population. The aggregation of toxic amyloid-beta (Aβ) is one of the main pathological hallmarks of the AD brain. Recently, neuroinflammation has been recognized as one of th...
Autores principales: | Liu, Jingshu, Liu, Sihan, Zeng, Li, Tsilioni, Irene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419190/ https://www.ncbi.nlm.nih.gov/pubmed/37569378 http://dx.doi.org/10.3390/ijms241512002 |
Ejemplares similares
-
Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome
por: Theoharides, Theoharis C., et al.
Publicado: (2019) -
Mast Cells, Stress, Fear and Autism Spectrum Disorder
por: Theoharides, Theoharis C., et al.
Publicado: (2019) -
The novel amyloid-beta peptide aptamer inhibits intracellular amyloid-beta peptide toxicity
por: Wang, Xu, et al.
Publicado: (2013) -
Mast Cells May Regulate The Anti-Inflammatory Activity of IL-37
por: Theoharides, Theoharis C., et al.
Publicado: (2019) -
Recombinant SARS-CoV-2 Spike Protein Stimulates Secretion of Chymase, Tryptase, and IL-1β from Human Mast Cells, Augmented by IL-33
por: Tsilioni, Irene, et al.
Publicado: (2023)